GOLDMAN SACHS GROUP INC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 61 filers reported holding ONCOCYTE CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q4 2022$19,751
-92.9%
61,548
-83.9%
0.00%
Q3 2022$279,000
-42.7%
381,532
-29.6%
0.00%
Q2 2022$487,000
-29.0%
541,983
+17.8%
0.00%
Q1 2022$686,000
-27.3%
460,004
+5.7%
0.00%
Q4 2021$944,000
-36.5%
435,040
+4.2%
0.00%
Q3 2021$1,487,000
-32.5%
417,515
+8.8%
0.00%
Q2 2021$2,203,000
+151.5%
383,853
+127.4%
0.00%
Q1 2021$876,000
+136.8%
168,779
+9.0%
0.00%
Q4 2020$370,000
+53.5%
154,778
-10.8%
0.00%
Q3 2020$241,000
+301.7%
173,427
+452.9%
0.00%
Q2 2020$60,000
+27.7%
31,367
+63.4%
0.00%
Q1 2020$47,0000.0%19,193
+3.9%
0.00%
Q2 2018$47,000
-23.0%
18,466
-36.8%
0.00%
Q1 2018$61,000
-72.0%
29,217
-30.5%
0.00%
Q2 2017$218,000
-0.5%
42,015
+14.3%
0.00%
Q1 2017$219,000
+108.6%
36,750
+24.3%
0.00%
Q2 2016$105,000
-21.6%
29,558
+1.3%
0.00%
Q1 2016$134,00029,1650.00%
Other shareholders
ONCOCYTE CORP shareholders Q3 2020
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 14,716,204$20,456,0001.61%
PURA VIDA INVESTMENTS, LLC 6,022,534$8,371,0000.43%
P.A.W. CAPITAL CORP 199,700$278,0000.30%
Penbrook Management LLC 229,425$319,0000.28%
PERKINS CAPITAL MANAGEMENT INC 39,725$55,0000.05%
GSA CAPITAL PARTNERS LLP 201,047$279,0000.05%
Private Wealth Partners, LLC 150,000$209,0000.02%
Phoenix Holdings Ltd. 317,138$426,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 255,300$355,0000.01%
ETF MANAGERS GROUP, LLC 157,933$226,0000.01%
View complete list of ONCOCYTE CORP shareholders